000 01402 a2200385 4500
005 20250514072335.0
264 0 _c20031023
008 200310s 0 0 eng d
022 _a0271-0749
024 7 _a10.1097/01.jcp.0000084031.22282.24
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZawertailo, Laurie A
245 0 0 _aComparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cJun 2003
300 _a269-80 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAnalysis of Variance
650 0 4 _aBarbiturates
_xblood
650 0 4 _aBehavior, Addictive
_xblood
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMeprobamate
_xblood
650 0 4 _aPsychomotor Performance
650 0 4 _aSubstance-Related Disorders
_xblood
650 0 4 _aTriazolam
_xblood
700 1 _aBusto, Usoa E
700 1 _aKaplan, Howard L
700 1 _aGreenblatt, David J
700 1 _aSellers, Edward M
773 0 _tJournal of clinical psychopharmacology
_gvol. 23
_gno. 3
_gp. 269-80
856 4 0 _uhttps://doi.org/10.1097/01.jcp.0000084031.22282.24
_zAvailable from publisher's website
999 _c12609971
_d12609971